Director Farah Champsi sold $9.5M of Kite Pharma, Inc.

Sold$9,509,766

$82.42Price

115,376Shares

−34%Stake

What KITE did after the filing

Prices for KITE after this filing aren't in yet.

Traded Thu, Apr 13. Filed Mon, Apr 17, 5:24 PM ET, after the close. Not investment advice.